OPTIMISMM Subanalyse: Sicherheit von Pomalidomid (POM), Bortezomib (BORT) und Dexamethason (DEX) (PVd) Behandlung ( Tx) nach einer vorherigen Therapielinie (LoT) bei Patienten (pts) mit rezidiviertem oder refraktarem multiplen Myelom (RRMM)

---

Weisel K., Dimopoulos M., Oriol A., Beksac M., Schjesvold F., Liberati A. M., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.45, no.SUPPL 2, pp.283, 2022 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 45 Issue: SUPPL 2
• Publication Date: 2022
• Journal Name: ONCOLOGY RESEARCH AND TREATMENT
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
• Page Numbers: pp.283
• Ankara University Affiliated: Yes